This multicenter randomized trial demonstrated that epicardial-endocardial hybrid ablation (HA) maintained superior effectiveness over endocardial catheter ablation (CA) for nonparoxysmal atrial fibrillation at 24 months (66.3 percent vs. 33.3 percent freedom from AF/atrial flutter/atrial tachycardia), with comparable safety rates and significantly fewer reinterventions after HA.
You are here:
Durable Effectiveness and Safety of Hybrid Ablation Versus Catheter Ablation: 2-year Results From the Randomized CEASE-AF Trial
Submitted by: Vincent Sier
Source: European Journal of Cardio-Thoracic Surgery
Keywords:
Author(s): Nicolas Doll, Timo Weimar, Dariusz A Kosior, Alan Bulava, Ales Mokracek, Gerold Mönnig, Jonathan Sahu, Steven Hunter, Maurits Wijffels, Bart van Putte, Norman Rüb, Petr Nemec, Tomas Ostrizek, Erik Fransen, Piotr Suwalski
